| Literature DB >> 34781975 |
Xiaoqing Wang1, He Li2, Conghu Yuan1, Hang Zhao3.
Abstract
OBJECTIVE: This study explored the risk factors influencing the length of hospital stay (LOS) and establish whether the type of anesthesia is independently associated with the LOS in patients after primary unilateral total knee arthroplasty (TKA).Entities:
Keywords: Length of hospital stay; Retrospective study; Total knee arthroplasty; Type of anesthesia
Mesh:
Substances:
Year: 2021 PMID: 34781975 PMCID: PMC8591843 DOI: 10.1186/s13018-021-02817-4
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Flowchart detailing the selection process for patients included in this retrospective analysis
Baseline characteristics of patients
| Variables | Total ( | GA ( | RA ( | |
|---|---|---|---|---|
| Race, | 0.019 | |||
| Chinese | 1945 (84.2) | 642 (81.2) | 1303 (85.8) | |
| Malay | 159 (6.9) | 63 (8) | 96 (6.3) | |
| Indian | 137 (5.9) | 61 (7.7) | 76 (5) | |
| Others | 68 (2.9) | 25 (3.2) | 43 (2.8) | |
| Gender, | 0.003 | |||
| Female | 1746 (75.6) | 628 (79.4) | 1118 (73.6) | |
| Male | 563 (24.4) | 163 (20.6) | 400 (26.4) | |
| BMI (Kg/m2) | 27.8 ± 5.7 | 28.0 ± 4.7 | 27.7 ± 6.2 | 0.338 |
| Age(years) | 66.5 ± 8.1 | 64.7 ± 8.3 | 67.4 ± 7.9 | < 0.001 |
| ASA status, | 0.009 | |||
| I | 155 (6.7) | 68 (8.6) | 87 (5.7) | |
| II | 2016 (87.3) | 668 (84.5) | 1348 (88.8) | |
| III | 138 (6.0) | 55 (7) | 83 (5.5) | |
| Details of operation | ||||
| LOS(Days) | 4.0 (3.0, 6.0) | 4.0 (4.0, 6.0) | 4.0 (3.0, 5.0) | < 0.001 |
| Operation duration (mins) | 75.0 (65.0, 95.0) | 80.0 (65.0, 95.0) | 75.0 (65.0, 95.0) | 0.228 |
| Day of week of operation, | 0.142 | |||
| Monday | 381 (16.5) | 144 (18.2) | 237 (15.6) | |
| Tuesday | 526 (22.8) | 184 (23.3) | 342 (22.5) | |
| Wednesday | 395 (17.1) | 126 (15.9) | 269 (17.7) | |
| Thursday | 522 (22.6) | 161 (20.4) | 361 (23.8) | |
| Friday | 365 (15.8) | 127 (16.1) | 238 (15.7) | |
| Saturday | 120 (5.2) | 49 (6.2) | 71 (4.7) | |
| Perioperative blood transfusion, | 0.021 | |||
| No | 2200 (95.3) | 742 (93.8) | 1458 (96) | |
| Yes | 109 (4.7) | 49 (6.2) | 60 (4) | |
| Patient comorbidities | ||||
| Preoperative Hb (g/dL) | 13.1 ± 1.5 | 13.1 ± 1.5 | 13.1 ± 1.4 | 0.57 |
| Smoking, | 0.069 | |||
| No | 2088 (90.4) | 728 (92) | 1360 (89.6) | |
| Yes | 221 (9.6) | 63 (8) | 158 (10.4) | |
| OSA, | 0.672 | |||
| No | 2098 (90.9) | 722 (91.3) | 1376 (90.6) | |
| Yes | 211 (9.1) | 69 (8.7) | 142 (9.4) | |
| DM, | 1.000 | |||
| No | 1869 (80.9) | 640 (80.9) | 1229 (81) | |
| Yes | 440 (19.1) | 151 (19.1) | 289 (19) | |
| IHD, | 0.950 | |||
| No | 2184 (94.6) | 749 (94.7) | 1435 (94.5) | |
| Yes | 125 (5.4) | 42 (5.3) | 83 (5.5) | |
| CCF, | 0.088 | |||
| No | 2292 (99.3) | 789 (99.7) | 1503 (99) | |
| Yes | 17 (0.7) | 2 (0.3) | 15 (1) | |
| CVA, | 1.000 | |||
| No | 2266 (98.1) | 776 (98.1) | 1490 (98.2) | |
| Yes | 43 (1.9) | 15 (1.9) | 28 (1.8) | |
| Creatinine > 2 mg/dL, | 0.719 | |||
| No | 2041 (88.4) | 702 (88.7) | 1339 (88.2) | |
| Yes | 17 (0.7) | 7 (0.9) | 10 (0.7) | |
| NA | 251 (10.9) | 82 (10.4) | 169 (11.1) |
Data presented are mean ± SD, median (Q1–Q3), or n (%)
GA general anesthesia, RA regional anesthesia, BMI body mass index, ASA Status American Society of Anesthesiologist Physical Status, Hb hemoglobin, LOS length of stay, OSA Obstructive sleep apnea, DM diabetes mellitus, IHD ischemic heart disease, CCF congestive cardiac failure, CVA cerebrovascular accidents, SD standard deviation, NA not recorded
Univariate analysis for LOS
| Covariate | ||
|---|---|---|
| Race | ||
| Chinese | Reference | |
| Malay | − 0.44 (− 1.19, 0.31) | 0.248 |
| Indian | 0.12 (− 0.68, 0.92) | 0.766 |
| Others | 0.51 (− 0.61, 1.63) | 0.368 |
| Gender | ||
| Female | Reference | |
| Male | − 0.1 (− 0.54, 0.34) | 0.669 |
| Age(years) | ||
| < 65 | Reference | |
| ≥ 65 | 0.77 (0.39, 1.15) | < 0.001 |
| BMI (kg/m2) | ||
| < 25 | Reference | |
| 25–29.9 | − 0.29 (− 0.74, 0.16) | 0.205 |
| ≥ 30 | 0.26 (− 0.76, 0.23) | 0.299 |
| Type of Anaesthesia | ||
| GA | 0.84 (0.44, 1.23) | < 0.001 |
| RA | Reference | |
| Operation duration (mins) | ||
| < 60 | Reference | |
| 60–90 | 0.16 (− 0.42, 0.73) | 0.594 |
| ≥ 90 | 0.66 (0.05, 1.28) | 0.033 |
| Day of week of operation | ||
| Monday | 1.26 (0.66,1.87) | < 0.001 |
| Tuesday | 1.00 (0.44, 1.56) | < 0.001 |
| Wednesday | 0.74 (0.14, 1.34) | 0.016 |
| Thursday | Reference | |
| Friday | 1.5 (0.88, 2.11) | < 0.001 |
| Saturday | 0.11 (− 0.81, 1.02) | 0.82 |
| Perioperative blood transfusion | ||
| No | Reference | |
| Yes | 6.81 (5.96, 7.65) | < 0.001 |
| ASA status | ||
| I | Reference | |
| II | 0.37 (− 0.38, 1.12) | 0.339 |
| III | 2.95 (1.9, 4) | < 0.001 |
| Preoperative Hb (g/dL) | ||
| < 11 | 1.28 (0.51, 2.05) | 0.001 |
| 11–12.9 | 0.63(0.24, 1.03) | 0.002 |
| ≥ 13 | Reference | |
| Smoking | ||
| No | Reference | |
| Yes | − 0.37 (− 1.02, 0.27) | 0.253 |
| OSA | ||
| No | Reference | |
| Yes | − 0.51 (− 1.16, 0.15) | 0.129 |
| DM | ||
| No | Reference | |
| Yes | 1.03 (0.55, 1.51) | < 0.001 |
| IHD | ||
| No | Reference | |
| Yes | 1.37 (0.54, 2.2) | 0.001 |
| CCF | ||
| No | Reference | |
| Yes | 6.5 (4.30, 8.69) | < 0.001 |
| CVA | ||
| No | Reference | |
| Yes | 1.04 (− 0.36, 2.44) | 0.144 |
| Creatinine > 2 mg/dL | ||
| No | Reference | |
| Yes | 6.86 (4.67, 9.06) | < 0.001 |
| NA | 0.09 (− 0.51, 0.69) | 0.770 |
GA general anesthesia, RA regional anesthesia, BMI body mass index, ASA Status American Society of Anesthesiologist Physical Status, Hb haemoglobin, LOS length of stay, OSA Obstructive sleep apnea, DM diabetes mellitus, IHD ischemic heart disease, CCF congestive cardiac failure, CVA cerebrovascular accidents, SD standard deviation, NA not recorded
Multivariate analyses of risk factors associated with LOS
| Model I | Model II | Model III | ||||
|---|---|---|---|---|---|---|
| Age (years) | ||||||
| Per 10 | 0.68 (0.45–0.91) | < 0.001 | 0.69 (0.46–0.93) | < 0.001 | 0.5 (0.27–0.73) | < 0.001 |
| < 65 | Reference | Reference | Reference | |||
| ≥ 65 | 0.77 (0.39–1.15) | < 0.001 | 0.77 (0.38–1.16) | < 0.001 | 0.48 (0.09–0.87) | 0.015 |
| Hb (g/dL) | ||||||
| < 11 | Reference | Reference | Reference | |||
| 11–12.9 | − 0.65 (− 1.43 to 0.14) | 0.109 | − 0.62 (− 1.4 to 0.17) | 0.124 | 0.34 (− 0.41 to 1.08) | 0.374 |
| ≥ 13 | -1.28 (-2.05 to − 0.51) | 0.001 | − 1.12 (− 1.89 to − 0.35) | 0.004 | 0.13 (− 0.6 to 0.87) | 0.721 |
| DM | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 1.03 (0.55–1.51) | < 0.001 | 0.97 (0.49–1.45) | < 0.001 | 0.8 (0.33–1.27) | 0.001 |
| CCF | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 6.5 (4.3–8.69) | < 0.001 | 6.28 (4.1–8.47) | < 0.001 | 4.1 (2.02–6.17) | < 0.001 |
| IHD | ||||||
| No | ||||||
| Yes | ||||||
| Operation duration (mins) | ||||||
| < 60 | Reference | Reference | Reference | |||
| 60–90 | 0.16 (− 0.42 to 0.73) | 0.594 | 0.19 (− 0.38 to 0.77) | 0.513 | 0.17 (− 0.37 to 0.7) | 0.544 |
| ≥ 90 | 0.66 (0.05–1.28) | 0.033 | 0.72 (0.11–1.32) | 0.021 | 0.49 (− 0.09 to 1.07) | 0.095 |
| Perioperative blood transfusion | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 6.81 (5.96–7.65) | < 0.001 | 6.62 (5.77–7.47) | < 0.001 | 5.71 (4.86–6.56) | < 0.001 |
| Creatinine > 2 mg/dL | ||||||
| No | Reference | Reference | Reference | |||
| Yes | 6.86 (4.67–9.05) | < 0.001 | 6.89 (4.7–9.07) | < 0.001 | 4.54 (2.46–6.62) | < 0.001 |
| NA | 0.09 (− 0.51 to 0.69) | 0.77 | 0.11 (− 0.49 to 0.71) | 0.722 | 0.09 (− 0.47 to 0.66) | 0.744 |
| ASA status | ||||||
| I | Reference | Reference | Reference | |||
| II | 0.37 (-0.38–1.12) | 0.339 | 0.2 (− 0.55 to 0.95) | 0.596 | 0.15 (− 0.56 to 0.85) | 0.684 |
| III | 2.95 (1.9–4) | < 0.001 | 2.68 (1.62–3.73) | < 0.001 | 1.72 (0.72–2.71) | 0.001 |
| Type of anesthesia | ||||||
| GA | 0.84 (0.44–1.23) | < 0.001 | 1.03 (0.63–1.43) | < 0.001 | 0.78 (0.41–1.66) | < 0.001 |
| RA | Reference | Reference | Reference | |||
Data presented are β and 95% CIs
Model I: We did not adjust any covariants
Model II: We adjusted age, gender and race
Model III: We adjusted age, gender, race, ASA status, Hb, smoking, Operation Duration, BMI, DM, creatinine > 2 mg/dL, IHD, CCF, CVA, Type of anesthesia, Day of week of operation and the perioperative blood transfusion. In each case, the model is not adjusted for the variable itself
GA general anesthesia, RA regional anesthesia, ASA Status American Society of Anesthesiologist Physical Status, Hb hemoglobin, DM diabetes mellitus, IHD ischemic heart disease, CCF congestive cardiac failure
Effect size of type of anesthesia on LOS in each group
| Subgroup | ||||
|---|---|---|---|---|
| Age(years) | 0.006 | |||
| < 65 | 940 | − 0.27 (− 0.73 to 0.19) | 0.247 | |
| ≥ 65 | 1369 | − 1.12 (− 1.66 to − 0.58) | < 0.001 | |
| Gender | 0.063 | |||
| Female | 1746 | − 0.68 (− 1.08 to − 0.29) | 0.001 | |
| Male | 563 | − 1.31 (− 2.30 to − 0.31) | 0.010 | |
| Preoperative Hb (g/dL) | 0.934 | |||
| < 11 | 156 | − 1.49 (− 2.68 to − 0.3) | 0.015 | |
| 11–12.9 | 868 | − 0.78 (− 1.49 to − 0.07) | 0.032 | |
| ≥ 13 | 1286 | − 0.79 (− 1.25 to − 0.34) | 0.001 | |
| BMI (kg/m2) | 0.01 | |||
| < 25 | 683 | − 1.92 (− 2.73 to − 1.11) | < 0.001 | |
| 25–29.9 | 986 | − 0.31(− 0.92 to 0.29) | 0.313 | |
| ≥ 30 | 640 | − 0.58(− 1.1 to − 0.06) | 0.029 | |
| ASA status | 0.526 | |||
| I | 155 | − 0.03 (− 0.79 to 0.73) | 0.934 | |
| II | 2016 | − 0.85 (− 1.23 to − 0.48) | < 0.001 | |
| III | 138 | − 1.12(− 4.65 to 2.41) | 0.536 | |
| Operation duration (mins) | 0.817 | |||
| < 60 | 308 | − 1.1 (− 1.81 to − 0.39) | 0.003 | |
| 60–89 | 1231 | − 0.82 (− 1.38 to − 0.26) | 0.004 | |
| ≥ 90 | 773 | − 0.72 (− 1.37 to − 0.08) | 0.028 | |
| DM | 0.061 | |||
| No | 1869 | − 0.64 (− 1.02 to − 0.26) | 0.001 | |
| Yes | 440 | − 1.6 (− 2.69 to − 0.51) | 0.004 |
We adjusted age, gender, race, ASA status, Hb, smoking, Operation Duration, BMI, DM, creatinine > 2 mg/dL, IHD, CCF, CVA, Type of anesthesia, Day of week of operation and the perioperative blood transfusion. In each case, the model is not adjusted for the variable itself
BMI body mass index, ASA Status American Society of Anesthesiologist Physical Status, Hb haemoglobin, DM diabetes mellitus